These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 580429)

  • 21. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoprolol--a new cardioselective beta adrenoceptor antagonist in experimental cardiac arrhythmias.
    Sivam SP; Seth SD
    Indian J Med Res; 1978 Jul; 68():176-82. PubMed ID: 700845
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolated paced guinea pig left atrium: a new ouabain-induced arrhythmia model.
    Thomas GP; Varma RK
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):459-62. PubMed ID: 1784143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiarrhythmic effect of prostaglandin E2 on catecholamine-induced arrhythmias.
    Mest HJ; Winkler J; Förster W
    Acta Biol Med Ger; 1977; 36(7-8):1193-6. PubMed ID: 612098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of combination of diphenylhydantoin and prostaglandin E2 on ouabain-induced arrhythmias].
    Xie H; Wang GX
    Yao Xue Xue Bao; 1988; 23(12):953-5. PubMed ID: 3256195
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of hypomagnesemia on ouabain-induced cardiac arrhythmias in dogs.
    Singh VP; Sharma PL; Wahi PL
    Indian J Med Res; 1975 Jul; 63(7):1029-35. PubMed ID: 1213789
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmic effects of derivatives of metoclopramide].
    Cheymol G; Mouillé P
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):150-9. PubMed ID: 1164083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of delta 1-tetrahydrocannabinol and propranolol on ouabain induced arrhythmias.
    Schaefer JF; Loetzer R; Sofia RD
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):5-10. PubMed ID: 4757849
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma CPU-86017 concentrations regarding suppression of ouabain-induced cardiac arrhythmias and decrease of heart rate in guinea pigs.
    Khan HH; Dai DZ; Xiao DW; Lin S; Wang ZZ; Lou S; Qing Q
    Acta Pharmacol Sin; 2000 Nov; 21(11):1039-42. PubMed ID: 11501061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of antiarrhythmic properties of quinicine versus quinidine (author's transl)].
    Pecquet-Bathellier C; Quevauviller A
    Sem Hop; 1978 Oct 8-15; 54(29-32):953-7. PubMed ID: 216087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
    Nakanishi M; Imamura H; Nakamura T
    Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
    [No Abstract]   [Full Text] [Related]  

  • 37. [Propranolol in digitalis intoxication].
    Karamehmet A; Aytan N; Ozcanli A
    Turk Tip Cemiy Mecm; 1969; 35(11):633-9. PubMed ID: 5375459
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective action of methyldopa against ouabain-induced cardiac arrhythmias and lethality.
    Thomas GP; Stephen PM
    Arch Int Pharmacodyn Ther; 1993; 323():23-31. PubMed ID: 8250641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of cardiac arrhythmias with beta-adrenergic blocking agents. Clinical and experimental studies.
    Wolfson S; Robbins SI; Krasnow N
    Am Heart J; 1966 Aug; 72(2):176-87. PubMed ID: 4380526
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation on the effect of propranolol (beta-adrenergic blockade) on arrhythmia during anesthesia].
    Aochi O; Goto Y; Takeshita S; Yasunaka H; Onagatani K
    Geka Chiryo; 1966 May; 14(5):602-12. PubMed ID: 6014152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.